Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Kidney Neoplasms × vatalanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioblastoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Somatostatinoma 1 Pheochromocytoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Non-hematologic Malignancies 1 Melanoma 1 Kidney Neoplasms 1 Insulinoma 1 Glucagonoma 1 Gliosarcoma 1 Glioma 1 Gastrinoma 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Medullary 1 Carcinoma, Islet Cell 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

pembrolizumab 11 Nivolumab 7 Cyclophosphamide 6 aldesleukin 5 Sunitinib 5 Sorafenib 5 Everolimus 5 temsirolimus 4 belzutifan 4 Ipilimumab 4 fludarabine 3 cabozantinib 3 atezolizumab 3 Interferon-alpha 3 Gene Expression Profiling 3 Fluorouracil 3 Docetaxel 3 Busulfan 3 sargramostim 2 perifosine 2 pazopanib 2 ixabepilone 2 entinostat 2 ciforadenant 2 belinostat 2 Thiotepa 2 Temozolomide 2 Sirolimus 2 Reverse Transcriptase Polymerase Chain Reaction 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00303732 2016-03-03

PTK/RAD

Duke University

Phase 1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡